PHARMOS CORP Net Income
PHARMOS CORP reported Net Income of -$331.48 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-11-19
- PHARMOS CORP net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$331.48K.
- PHARMOS CORP net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$382.88K.
- PHARMOS CORP net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$576.30K.
- PHARMOS CORP net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$429.38K.
- PHARMOS CORP net income (loss) attributable to parent for fiscal 2011 was -$1.98M.
- PHARMOS CORP net income (loss) attributable to parent for fiscal 2010 was -$1.55M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$331.48K 10-Q · filed 2012-11-19 | -$714.36K derived: sum of 2 quarters · filed 2012-11-19 | -$1.29M 10-Q · filed 2012-11-19 | -$1.72M derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-06-30 | -$382.88K 10-Q · filed 2012-07-30 | -$959.18K 10-Q · filed 2012-07-30 | -$1.39M derived: sum of 3 quarters · filed 2012-07-30 | -$1.83M derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-03-31 | -$576.30K 10-Q · filed 2012-04-16 | -$1.01M derived: sum of 2 quarters · filed 2012-04-16 | -$1.45M derived: sum of 3 quarters · filed 2012-11-19 | -$1.95M derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-12-31 | -$429.38K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | -$875.41K derived: sum of 2 quarters · filed 2012-11-19 | -$1.38M derived: sum of 3 quarters · filed 2012-11-19 | -$1.98M 10-K/A · filed 2012-02-21 |
| 2011-09-30 | -$446.04K 10-Q · filed 2012-11-19 | -$946.47K derived: sum of 2 quarters · filed 2012-11-19 | -$1.55M 10-Q · filed 2012-11-19 | -$1.70M derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-06-30 | -$500.43K 10-Q · filed 2012-07-30 | -$1.10M 10-Q · filed 2012-07-30 | -$1.26M derived: sum of 3 quarters · filed 2012-07-30 | -$1.73M derived: sum of 4 quarters · filed 2012-07-30 |
| 2011-03-31 | -$603.13K 10-Q · filed 2012-04-16 | -$755.21K derived: sum of 2 quarters · filed 2012-04-16 | -$1.23M derived: sum of 3 quarters · filed 2012-04-16 | -$1.66M derived: sum of 4 quarters · filed 2012-04-16 |
| 2010-12-31 | -$152.09K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | -$622.39K derived: sum of 2 quarters · filed 2012-02-21 | -$1.05M derived: sum of 3 quarters · filed 2012-02-21 | -$1.55M 10-K/A · filed 2012-02-21 |
| 2010-09-30 | -$470.30K 10-Q · filed 2011-10-31 | -$902.28K derived: sum of 2 quarters · filed 2011-10-31 | -$1.39M 10-Q · filed 2011-10-31 | |
| 2010-06-30 | -$431.98K 10-Q · filed 2011-08-08 | -$923.36K 10-Q · filed 2011-08-08 |